HUMULIN I 100 IU/ML Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin i 100 iu/ml suspension for injection

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulin (human) - humulin - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

HUMULIN M 100 IU/ML Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin m 100 iu/ml suspension for injection

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting - humulin m3 - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

HUMULIN S 100 IU/ML Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin s 100 iu/ml solution for injection

eli lilly and company limited - human insulin (recombinant dna origin) - solution for injection - 100 iu/ml - insulins and analogues for injection, fast-acting - humulin s - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

HUMULIN I KWIKPEN 100 IU/ML Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin i kwikpen 100 iu/ml suspension for injection

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulin (human) - humulin i - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

HUMULIN M 100 IU/ML Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin m 100 iu/ml suspension for injection

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting - humulin m3 - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis